
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
A REVIEW BY CLITOREA TERNATEA
Sangram Nagargoje*, Salas Satpute, Vaishnavi Katmande
. Abstract Clitorieaternatea (CT) is an herbal plant that has the potential as a therapeutic agent to manage polycystic ovarian syndrome (PCOS). CT has antioxidant and anti- inflammatory properties that can help reduce inflammation, oxidative stress, and metabolic dysfunction associated with PCOS. In this study, we conducted a systematic review of relevant research articles on the bioactivity potential of CT as a herbal drug candidate for PCOS. We searched research articles in Indonstian and English published our the last five years (2019-2023) through three databases., PubMed, Science Direct, and Google Scholer. We use established inclusion and exclusion criteria to select suitable articles. Out of 24 research articles included in our systematic review, We found that CT has potential as an antidibatic, antiglucose, anticholesterol, antiobesity, antiinflammatory, hepatoprotective, and antidepressant agent. Based on our systematic review, CT shows potential as a therapeutic agent for managing PCOS symptoms. The antioxidant and anti-inflammatory propertis of CT can help reduce inflammation, oxidative stress, and metabolic dysfunctions associated with PCOS. However, further research is needed to validate these finding and evaluate the effectiveness of CT in clinical settings. Keywords: Bioactivity; clitorea ternatea; herbal drug; polycystic ovary syndrome; pharmacology; pharmacognosy. [Full Text Article] [Download Certificate] |
